Javelin Oncology
Lebanon, US · Founded 2017 · Delaware corporation
Founders & leadership
JR
Jake RederNamed on SEC filing
MM
Matthew MartinNamed on SEC filing
AC
Anthony CooperNamed on SEC filing
EA
Eric AchtmanNamed on SEC filing
DR
Daniel RhodesNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2019
▶$1.5MraisedDec 2019 · 10 investors · Other Health CareRule 506(b)
▶$1.5MraisedDec 2019 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Jake RederDirector
- Matthew MartinExecutive Officer
- Anthony CooperExecutive Officer
- Eric AchtmanDirector
- Daniel RhodesExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.5M
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Javelin Oncology raised?
- Javelin Oncology has disclosed $1.5M raised across 1 round.
- Where is Javelin Oncology headquartered?
- Javelin Oncology is headquartered in Lebanon, US.